These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23919478)

  • 41. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery.
    Moazeni E; Gilani K; Sotoudegan F; Pardakhty A; Najafabadi AR; Ghalandari R; Fazeli MR; Jamalifar H
    J Microencapsul; 2010; 27(7):618-27. PubMed ID: 20681747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance.
    Shah SP; Misra A
    AAPS PharmSciTech; 2004 Aug; 5(4):e65. PubMed ID: 15760062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol.
    Dhand R
    Respir Care; 2002 Dec; 47(12):1406-16; discussion 1416-8. PubMed ID: 12467499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation.
    Sebti T; Pilcer G; Van Gansbeke B; Goldman S; Michils A; Vanderbist F; Amighi K
    Eur J Pharm Biopharm; 2006 Aug; 64(1):26-32. PubMed ID: 16697169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liposomal amphotericin B dry powder inhaler: effect of fines on in vitro performance.
    Shah SP; Misra A
    Pharmazie; 2004 Oct; 59(10):812-3. PubMed ID: 15544064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing a system to capture stray aerosol during inhalation of nebulized liposomal cisplatin.
    Wittgen BP; Kunst PW; Perkins WR; Lee JK; Postmus PE
    J Aerosol Med; 2006; 19(3):385-91. PubMed ID: 17034313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Air and soul: the science and application of aerosol therapy.
    Rubin BK
    Respir Care; 2010 Jul; 55(7):911-21. PubMed ID: 20587104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary effects of chronic exposure to liposome aerosols in mice.
    Myers MA; Thomas DA; Straub L; Soucy DW; Niven RW; Kaltenbach M; Hood CI; Schreier H; Gonzalez-Rothi RJ
    Exp Lung Res; 1993; 19(1):1-19. PubMed ID: 8440200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model.
    Koshkina NV; Waldrep JC; Roberts LE; Golunski E; Melton S; Knight V
    Clin Cancer Res; 2001 Oct; 7(10):3258-62. PubMed ID: 11595722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aerosols for systemic delivery of macromolecules.
    Newhouse MT; Corkery KJ
    Respir Care Clin N Am; 2001 Jun; 7(2):261-75, vi. PubMed ID: 11517023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats.
    Malinin V; Neville M; Eagle G; Gupta R; Perkins WR
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6540-6549. PubMed ID: 27550345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhaled Liposomal Antimicrobial Delivery in Lung Infections.
    Bassetti M; Vena A; Russo A; Peghin M
    Drugs; 2020 Sep; 80(13):1309-1318. PubMed ID: 32691293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhaled antibodies: formulations require specific development to overcome instability due to nebulization.
    Mayor A; Thibert B; Huille S; Respaud R; Audat H; Heuzé-Vourc'h N
    Drug Deliv Transl Res; 2021 Aug; 11(4):1625-1633. PubMed ID: 33768475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delivery of biotherapeutics by inhalation aerosol.
    Niven RW
    Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):151-231. PubMed ID: 9501969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a liposome-based formulation for vitamin K1 nebulization on the skin.
    Campani V; Marchese D; Pitaro MT; Pitaro M; Grieco P; De Rosa G
    Int J Nanomedicine; 2014; 9():1823-32. PubMed ID: 24748792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nebulization of niosomal all-trans-retinoic acid: an inexpensive alternative to conventional liposomes.
    Desai TR; Finlay WH
    Int J Pharm; 2002 Jul; 241(2):311-7. PubMed ID: 12100858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.